Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
4.060
+0.160 (4.10%)
At close: Jun 6, 2025, 4:00 PM
4.060
0.00 (0.00%)
After-hours: Jun 6, 2025, 5:45 PM EDT
Jaguar Health Employees
Jaguar Health had 49 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
49
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$235,755
Profits / Employee
-$810,816
Market Cap
5.13M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
JAGX News
- 9 hours ago - Jaguar Health to Conduct Fireside Chat June 10 Regarding Company's Efforts to Further its Orphan Disease Development Programs as Part of Lytham Partners' Spring 2025 Spotlight Series - Accesswire
- 16 days ago - Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Accesswire
- 17 days ago - First Patient Randomized in Jaguar Health's Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Crofelemer in Pediatric Patients with Microvillus Inclusion Disease (MVID) - Accesswire
- 21 days ago - Jaguar Health, Inc. (JAGX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Jaguar Health Reports First Quarter 2025 Financials - Accesswire
- 23 days ago - Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates - Accesswire
- 4 weeks ago - Jaguar Health Celebrates National Pet Cancer Awareness Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs - Accesswire
- 4 weeks ago - Jaguar Health Provides Overview of 2025 Crofelemer-Related Catalysts - Accesswire